Wall Street Experts
ver. ZuMIgo(08/25)
Astec LifeSciences Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 3 725
EBIT TTM (mln): -1 042
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
Rok finansowy |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2025 |
Przychód (mln) |
552 |
844 |
1,119 |
1,094 |
1,128 |
1,748 |
2,070 |
2,665 |
2,593 |
2,987 |
3,613 |
4,309 |
5,226 |
5,549 |
6,766 |
6,282 |
4,582 |
3,813 |
Przychód Δ r/r |
0.0% |
53.0% |
32.6% |
-2.2% |
3.1% |
54.9% |
18.4% |
28.8% |
-2.7% |
15.2% |
21.0% |
19.3% |
21.3% |
6.2% |
21.9% |
-7.2% |
-27.1% |
-16.8% |
Marża brutto |
38.4% |
32.6% |
28.9% |
22.2% |
31.2% |
32.6% |
29.7% |
31.5% |
31.8% |
39.8% |
34.3% |
34.6% |
34.8% |
37.8% |
42.2% |
36.1% |
8.9% |
22.1% |
EBIT (mln) |
95 |
124 |
172 |
70 |
18 |
85 |
111 |
190 |
-174 |
510 |
564 |
685 |
685 |
897 |
1,203 |
435 |
-422 |
233 |
EBIT Δ r/r |
0.0% |
31.4% |
38.4% |
-59.5% |
-74.1% |
372.1% |
31.1% |
70.2% |
-191.9% |
-392.5% |
10.6% |
21.4% |
-0.1% |
31.0% |
34.1% |
-63.9% |
-197.0% |
-155.2% |
EBIT (%) |
17.1% |
14.7% |
15.3% |
6.4% |
1.6% |
4.9% |
5.4% |
7.1% |
-6.7% |
17.1% |
15.6% |
15.9% |
13.1% |
16.2% |
17.8% |
6.9% |
-9.2% |
6.1% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
79 |
114 |
115 |
122 |
107 |
124 |
126 |
48 |
91 |
207 |
252 |
367 |
EBITDA (mln) |
158 |
216 |
255 |
158 |
158 |
263 |
360 |
536 |
242 |
662 |
769 |
901 |
972 |
1,193 |
1,628 |
893 |
-59 |
-662 |
EBITDA(%) |
28.7% |
25.6% |
22.8% |
14.5% |
14.0% |
15.1% |
17.4% |
20.1% |
9.3% |
22.2% |
21.3% |
20.9% |
18.6% |
21.5% |
24.1% |
14.2% |
-1.3% |
-17.4% |
Podatek (mln) |
14 |
17 |
33 |
21 |
5 |
28 |
25 |
42 |
16 |
96 |
207 |
201 |
138 |
240 |
312 |
94 |
-149 |
63 |
Zysk Netto (mln) |
79 |
104 |
132 |
49 |
14 |
60 |
87 |
148 |
-192 |
191 |
349 |
357 |
475 |
650 |
899 |
256 |
-469 |
-1,348 |
Zysk netto Δ r/r |
0.0% |
30.6% |
27.3% |
-62.9% |
-72.1% |
335.8% |
45.8% |
70.3% |
-229.7% |
-199.8% |
82.6% |
2.4% |
32.9% |
36.9% |
38.1% |
-71.5% |
-283.6% |
187.1% |
Zysk netto (%) |
14.4% |
12.3% |
11.8% |
4.5% |
1.2% |
3.4% |
4.2% |
5.5% |
-7.4% |
6.4% |
9.7% |
8.3% |
9.1% |
11.7% |
13.3% |
4.1% |
-10.2% |
-35.3% |
EPS |
8.42 |
11.0 |
10.98 |
2.89 |
0.81 |
3.45 |
4.74 |
7.91 |
-9.85 |
9.81 |
17.88 |
18.28 |
24.29 |
33.23 |
45.87 |
13.04 |
-23.96 |
-68.71 |
EPS (rozwodnione) |
8.42 |
11.0 |
10.98 |
2.89 |
0.81 |
3.43 |
4.74 |
7.91 |
-9.82 |
9.78 |
17.84 |
18.26 |
24.27 |
33.21 |
45.85 |
13.04 |
-23.96 |
-68.71 |
Ilośc akcji (mln) |
9 |
9 |
12 |
17 |
17 |
17 |
18 |
19 |
19 |
19 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
Ważona ilośc akcji (mln) |
9 |
9 |
12 |
17 |
17 |
17 |
18 |
19 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
20 |
Waluta |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |
INR |